Heerlen, NL, 19 April 2023 21:30 CET
Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.
Pursuant to commitments entered into prior to issuing the Offering Circular, DSM will deliver 7,796 DSM-Firmenich ordinary shares to employees in view of transactions that occurred on 19 April 2023, being: (i) settlement of the vesting of 386 share units that have been granted subject to the respective DSM Incentive Plan and (ii) settlement of the exercise of 7,410 stock options granted under the respective DSM Incentive Plan (average exercise price € 55.03).
This is a press release by Koninklijke DSM N.V. (DSM) in connection with the voluntary public exchange offer by DSM-Firmenich AG (DSM-Firmenich) for all the issued and outstanding ordinary shares in the share capital of DSM (the Exchange Offer), pursuant to Section 13, paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft (the Decree). The Exchange Offer is not being made, and the DSM ordinary shares will not be accepted for purchase from or on behalf of any holder of DSM ordinary shares, in any jurisdiction in which the making of the Exchange Offer or acceptance thereof would not be in compliance with the securities or other laws or regulations of such jurisdiction or would require any registration, approval or filing with any regulatory authority not expressly contemplated by the terms of the offering circular in relation to the Exchange Offer dated 22 November 2022 (the Offering Circular).
Senior Director External Communications
+31 45 578 2420
Vice-President Investor Relations
+31 45 578 2864